Full-Time

Medical Science Liaison/Senior Medical Science Liaison

Alzheimer's Disease Agitation, Midwest Region

Confirmed live in the last 24 hours

Axsome Therapeutics Inc

Axsome Therapeutics Inc

201-500 employees

Develops therapies for CNS disorders

Biotechnology
Healthcare

Compensation Overview

$150k - $200kAnnually

+ Annual Bonus + Equity

Mid, Senior

North Dakota, USA + 12 more

More locations: Iowa, USA | Mississippi, USA | Tennessee, USA | Minnesota, USA | Kentucky, USA | Wisconsin, USA | Missouri, USA | Ohio, USA | Indiana, USA | Michigan, USA | Illinois, USA | Alabama, USA

Field-based position covering the Midwest Region. Candidates must reside within the geography.

Category
Physicians & Surgeons
Medical, Clinical & Veterinary
Requirements
  • Advanced degree (MD, PharmD or PhD) required
  • Previous MSL experience is preferred
  • Preference for candidates with Alzheimer’s Disease or Geriatric Psychiatry experience
  • Candidate must reside within the geographic area
  • Ability to travel up to 50-75%, including overnight stays and weekend, as needed
  • Meet requirements for health industry representative credentialing to gain access to healthcare facilities within the territory
Responsibilities
  • Systematically identify and develop relationships with healthcare professionals (HCPs) and key opinion leaders (KOLs) to raise awareness of Axsome’s mission to accelerate the invention and adoption of life-changing medicines for patients living with CNS disorders
  • Develop and maintain a deep knowledge and understanding of neuropsychiatry and approved pipeline medications as well as the competitive landscape in the specified therapeutic area
  • Provide fair and balanced scientific information to HCPs and to internal business partners per organizational needs
  • Upon request, provide formal presentations to HCPs, external stakeholders, etc.
  • Communicate meaningful insights gleaned from peer-to-peer discussions with HCPs
  • Identify, analyze, and translate specific needs within the territory to achieve clinical and business objectives
  • Collaborate with internal partners, as appropriate, to advance clinical and business objectives
  • Build and maintain technical and clinical expertise in neuropsychiatry and across other neuroscience therapeutic areas as required
  • Actively contribute to the growth and development of the National Field Medical Team
  • Execute key job functions, including documentation of field activities, submission of medical insights, completion of medical information requests, expense report submission, required trainings, and other tasks as necessary
  • Provide high level support for company sponsored trials and aide in navigating investigator-initiated research proposals through the review process when needed
Axsome Therapeutics Inc

Axsome Therapeutics Inc

View

Axsome Therapeutics develops therapies for central nervous system (CNS) disorders, focusing on conditions like major depressive disorder, treatment-resistant depression, and Alzheimer's agitation. Their main product, AXS-05, is an oral medication that works by blocking NMDA receptors in the brain to help regulate mood. This drug has shown positive results in clinical trials and has received FDA Breakthrough Therapy Designation, which helps speed up its approval process. Unlike many competitors, Axsome emphasizes addressing unmet medical needs in CNS disorders and aims to improve patient outcomes through rigorous research and development. The company's goal is to bring effective treatments to market, enhancing the quality of life for patients suffering from these conditions.

Company Stage

IPO

Total Funding

$430.7M

Headquarters

New York City, New York

Founded

2012

Growth & Insights
Headcount

6 month growth

3%

1 year growth

3%

2 year growth

3%
Simplify Jobs

Simplify's Take

What believers are saying

  • The launch of Auvelity and the promising results of AXS-12 in Phase 3 trials indicate strong potential for revenue growth and market impact.
  • Axsome's strategic expansion of its sales force to support Auvelity's launch demonstrates its commitment to commercial success.
  • The appointment of experienced leaders like Dr. Sue Mahony to the board enhances Axsome's strategic direction and governance.

What critics are saying

  • The biopharmaceutical sector's inherent risks, including regulatory hurdles and clinical trial failures, could impact Axsome's progress.
  • High competition in the CNS disorder treatment market may challenge Axsome's ability to capture significant market share.

What makes Axsome Therapeutics Inc unique

  • Axsome Therapeutics focuses on CNS disorders with a strong emphasis on unmet medical needs, setting it apart from broader biopharmaceutical companies.
  • The FDA Breakthrough Therapy Designation for AXS-05 highlights its innovative approach and potential for rapid market entry.
  • Axsome's diversified pipeline, including treatments for MDD, TRD, Alzheimer's agitation, and narcolepsy, showcases its comprehensive strategy in CNS therapeutics.

Help us improve and share your feedback! Did you find this helpful?